Carl Icahn's Growing Biogen Front

| About: Biogen Inc. (BIIB)

He's back with three more directors nominated for the company's board. There are two Icahnians there already, and this round of proxy voting will say a lot about whether shareholders think that taking Biogen (NASDAQ:BIIB) down the road that Imclone (OTCPK:IMCL) went is a good thing or not.

Stay tuned...